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An Allelic Series at the PDGFR Locus Indicates
Unequal Contributions of Distinct
Signaling Pathways During Development
many studies have taken advantage of the finding that
different SH2 domain-containing proteins bind preferen-
tially to distinct phosphotyrosine residues on RTKs
(Pawson, 1995; Songyang et al., 1993). Conversion of
receptor tyrosine residues to phenylalanine can be em-
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1100 Fairview Avenue North ployed to uncouple RTK activation from the activation
of specific downstream signaling pathways. Intriguingly,Seattle, Washington 98109
studies on cells in culture expressing signaling mutant
RTKs have led to contrasting theories regarding whether
different signaling proteins play specific or redundantSummary
roles following receptor activation (Fambrough et al.,
1999; Rosenkranz et al., 1999; Valius and Kazlauskas,A central issue in signal transduction is the physiologi-
1993). Therefore, one of the best ways to define howcal contribution of different growth factor-initiated sig-
distinct signaling pathways are utilized by RTKs to directnaling pathways. We have generated knockin mice
multiple biological events may be through analysis ofharboring mutations in the PDGF receptor (PDGFR)
whole organisms.that selectively eliminate its capacity to activate PI3
To further understand how individual RTK-activatedkinase (PI3K) or Src family kinases (Src). ThePI3K muta-
signaling pathways contribute to receptor function in ation leads to neonatal lethality due to impaired signal-
physiological context, we have focused on how targeteding in many cell types, but theSrc mutation only affects
mutations of the two receptors for platelet-derivedoligodendrocyte development. A third knockin line con-
growth factor (PDGFRs) affect mouse development. Thetaining mutations that eliminate multiple docking sites
PDGFRs provide an excellent model for this analysis,does not increase the severity of thePI3K mutation. How-
since both receptors have been well characterized bio-ever, embryos with mutations in the PI3K binding sites
chemically, and at least some of the signaling proteinsof both PDGFRs ( and ) recapitulate the PDGFR null
activated by the PDGFRs bind to specific receptor auto-phenotype. Our results indicate that PI3K has a predomi-
phosphorylation sites. Targeted deletion of each PDGFRnant role in PDGFR signaling in vivo and that RTK-
leads to distinct phenotypes. Complete loss of PDGFRactivated signaling pathways execute both specific and
signaling results in embryonic lethality between E8 andoverlapping functions during mammalian development.
E16. PDGFR null embryos display a complex pheno-
type characterized by a cleft face, abnormally patternedIntroduction
somites, subepidermal blebbing, spina bifida, cervical
vertebrae and rib fusions, malformation of the shoulderUpon binding to ligand, activated transmembrane re-
girdle, and hemorrhaging. These defects are due to ab-ceptor tyrosine kinases (RTKs) trigger multiple intracel-
normal function of a variety of cells including derivativeslular signaling pathways that relay the receptor’s signal
of the sclerotome and nonneuronal neural crest cellsto appropriate cellular targets. Signal transmission by
(Soriano, 1997; Tallquist et al., 2000b). Furthermore,RTKs entails ligand-induced receptor dimerization, au-
studies on the population of surviving mice homozygoustophosphorylation on specific intracellular tyrosine resi-
for a null allele of PDGFA, a PDGFR-specific ligand,dues, and binding to those residues by intracellular sig-
have expanded the diverse array of cells known to re-naling proteins containing phosphotyrosine recognition
quire PDGFR signaling for normal development to in-modules such as SH2 and PTB domains. These effectors
clude oligodendrocytes, lung alveolar myofibroblasts,are often enzymes activated following receptor associa-
intestinal mesenchyme, and Leydig cells (reviewed intion and include proteins that modify lipids such as phos-
Betsholtz et al., 2001). In contrast, loss of PDGFR sig-phatidyl inositol 3-kinase (PI3K) and phospholipase C
naling in mice leads to abnormal development of a more(PLC), cytoplasmic tyrosine kinases such as Src, tran-
restricted set of cell types. These include vascularscription factors such as STATs, and tyrosine phospha-
smooth-muscle cells and related cells that coat the mi-tases such as SHP-2. RTKs also bind to nonenzymatic
crovasculature such as pericytes and kidney mesangialadaptor proteins such as Grb2, Shc, Nck, and Crk (Cant-
cells (Hellstro¨m et al., 1999; Leve´en et al., 1994; Lindahlley et al., 1991; Pawson and Scott, 1997). One prominent
et al., 1997; Soriano, 1994). Consistent with the role ofaim in the field of cellular signal transduction is to deter-
these cells in maintaining the integrity of the vasculature,mine which distinct signaling proteins contribute to an
PDGFR knockout mice die perinatally and exhibit sys-RTK’s ability to initiate cellular responses upon expo-
temic vascular defects (Soriano, 1994).sure to ligand, thus enabling RTKs to orchestrate spe-
Studies designed to determine the relative importancecific events during organismal development.
of individual signaling pathways to PDGFR function inTo assess the contribution of different effector proteins
vivo have thus far focused on two proteins: PI3K andand downstream signaling cascades to RTK function,
PLC. Despite in vitro evidence that clearly shows the
importance of these enzymes in PDGFR-mediated mi-1 Correspondence: psoriano@fhcrc.org
togenesis and chemotaxis (Kundra et al., 1994; Valius2 Present address: CEPTYR, Inc., 22215 26th Avenue SE, Bothell,
Washington 98021. and Kazlauskas, 1993), mice harboring mutations in the
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PI3K or PI3KPLC binding sites of the receptor de- with PDGFAA, based on assays for phosphorylation of
MAP kinase and the PDGFR itself (Figures 2A–2C).velop overtly normal (Heuchel et al., 1999; Tallquist et
al., 2000a). In vivo challenge assays and chimeric analy- None of the receptor mutants displayed decreased ac-
tivity in an in vitro kinase assay (data not shown). How-sis do show that loss of these signals results in subopti-
mal vascular smooth-muscle cell function. However, ever, the PI3K line did show a modest but reproducible
reduction in MAPK phosphorylation consistent with pre-overall, these studies are consistent with the idea that
individual signals transmitted by the PDGFR promote vious literature describing a role for PI3K in this pathway
(Rosenkranz et al., 1999).highly overlapping functions.
Here we have generated an allelic series of PDGFR It has been shown previously that mutation of the
PDGFR juxtamembrane autophosphorylation sitesautophosphorylation mutant knockin mice to analyze
whether different signaling pathways mediate specific (Y572/Y574) eliminates SFK binding to the receptor
(Gelderloos et al., 1998; Hooshmand-Rad et al., 1998).or redundant functions in vertebrate development. This
analysis demonstrates that while oligodendrocyte de- As expected from these reports, Src family kinase (SFK)
immunoprecipitates from wt and PI3K but not from Srcvelopment is affected in all signaling mutants, only the
mutant that cannot engage PI3K (designated PI3K) dis- cells displayed PDGF-inducible tyrosine phosphoryla-
tion and modest activation in an in vitro kinase assayplays abnormal skeletal development. The phenotype
of embryos expressing a PDGFR bearing mutations in (Figures 2D–2F). While these results were consistent
with previous literature, another result was unexpected.multiple autophosphorylation sites (those that bind
PI3K, Src family kinases, SHP-2, and PLC) is similar to We were unable to find anti-PDGFR and anti-SFK anti-
bodies sensitive enough to detect direct association ofthat of the PI3K mutation alone. However, consistent with
the idea that cooperation between the two PDGFRs via the PDGFR and SFKs by coimmunoprecipitation/West-
ern blot in any of our cell lines (data not shown). However,heterodimerization can lead to PI3K activation in vivo,
crosses between PI3K mice and mice harboring the analo- we detected a PDGF-inducible tyrosine phosphorylated
protein that migrates at the appropriate size for thegous mutation in the PDGFR recapitulates the PDGFR
null phenotype. These results suggest that while different PDGFR (170 kDa) in SFK immunoprecipitates from all
our cell lines (Figure 2E). If p170 represents the PDGFR,signaling pathways initiated by the PDGFR direct some
overlapping functions in vivo, signaling through PI3K rep- one explanation for this discrepancy is that our mutants
are expressed in primary mouse embryonic fibroblasts,resents a particularly efficient mechanism for promoting
certain developmental functions of the PDGFR, such as whereas previous studies analyzed immortalized cell
lines. This may be of particular importance consideringskeletal patterning.
that PDGFRs and some SFKs colocalize to caveolae, and
the composition of these structures is known to changeResults
upon cellular immortalization (Koleske et al., 1995; Liu
et al., 1996; Schlegel et al., 2000). It is possible thatDerivation of Knockin Mice
components of normal caveolae that facilitate SFK andWe have previously described a generic knockin vector
PDGFR association are lost upon immortalization. It isthat simultaneously disrupts expression of the endogenous
equally possible that in the absence of the juxtamem-pdgfr gene and allows expression of various PDGFR
brane binding sites, low-level binding to the PDGFRcDNAs under control of the endogenous PDGFR pro-
by SFKs can occur at an alternative tyrosine phosphory-moter. Using this vector, we have found that knockin of
lation site. While a low level of association between thea wt PDGFR cDNA rescues normal development in the
PDGFR and SFKs may occur in the absence of themouse (Klinghoffer et al., 2001). To assess the contribu-
juxtamembrane autophosphorylation sites in primarytion of different signaling proteins to PDGFR function
cells, our data suggest that these sites are requiredin vivo, we have now used a similar type of vector to
for normal levels of SFK tyrosine phosphorylation andgenerate mice harboring tyrosine to phenylalanine mu-
activation in response to PDGFAA.tations of the PDGFR previously shown to selectively
Assays designed to test whether mutation of auto-eliminate its ability to bind either PI3K (designated PI3K;
phosphorylation sites (Y731/Y742) in the kinase insertYu et al., 1991) or the Src family kinases (designated
domain of the PDGFR prevented binding and activationSrc; Gelderloos et al., 1998; Hooshmand-Rad et al., 1998;
of PI3K demonstrated that this mutation acted as pre-Figure 1A). Correctly targeted ES cell clones were identi-
dicted based on previous literature. In response to PDGF,fied by Southern blot analysis as previously described
the p85 subunit of PI3K associated with wt and Src(Figure 1B and data not shown; Klinghoffer et al., 2001).
receptors but not with the PI3K mutant (Figures 2G andTwo clones of each were used to derive germline chime-
2H). Furthermore, PDGF-induced phosphorylation of theras that gave rise to the PI3K and Src strains. Western
kinase Akt, a downstream effector of PI3K, was severelyblots on knockin mutant embryo lysates showed compa-
reduced in PI3K cells (Figures 2J and 2K). Importantly,rable expression of the receptor in all lines (Figure 1C).
both the PI3K and Src mutant receptors were able to
bind proteins, such as SHP-2, that were not predictedBiochemical Analysis of PDGF-Induced
to be affected by the introduced mutations (Figure 2I).Signaling in Mutant Fibroblasts
To determine whether the mutant PDGFRs were signal-
ing in the predicted manner, primary fibroblasts were Perinatal Lethality and Abnormal Skeletal
Development in PI3K but Not Src Homozygotesderived from homozygous mutant and wild-type em-
bryos. All cells expressed similar levels of PDGFR, and Genotyping of offspring derived from heterozygous
knockin parents, performed 7–14 days following birth,as expected, all lines were activated upon stimulation
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Figure 1. The Allelic Series of PDGFR-Sig-
naling Mutant cDNA Knockins
(A) Schematic of the PDGFR signaling mu-
tants used in this study. Autophosphorylation
sites within the intracellular domain are des-
ignated by solid black circles. Tyrosine-to-
phenylalanine mutations introduced to un-
couple the PDGFR from specific signaling
proteins are indicated with “F”s. The signal-
ing proteins predicted to be affected by the
mutation(s) are listed to the right.
(B) Targeting of the pdgfr genomic locus
with the PDGFR cDNA knockin vectors was
performed exactly as previously described
(Klinghoffer et al., 2001). Southern blot analy-
sis of wild-type (/) and PI3K targeted
(/PI3K) ES cell DNA digested with NheI. The
appearance of novel fragments, 8.7 kb and
4 kb upon NheI digestion indicates correct
targeting of the locus. Analysis of Src and F7
clones produced the same result shown for
the PI3K clone (data not shown).
(C) Western blot analysis of PDGFR expres-
sion. Whole E12.5 embryo lysates were sub-
jected to SDS-PAGE and blotted for the
PDGFR or RasGAP as a loading control. The
two bands observed on the blot represent the
mature, glycosylated (upper), and immature,
nonglycosylated (lower) forms of the PDGFR.
showed that while Src homozygotes were recovered at This defect was never observed in either PI3K heterozy-
gotes or Src homozygotes. Further analysis revealedthe expected Mendelian frequency (97 Src/Src out of
376 offspring, 26%) very few PI3K homozygotes survived that while PI3K-signaling mutants did not exhibit skeletal
defects such as rib fusions observed in PDGFR nullto this age (9 PI3K/PI3K out of 455 offspring, 2%). All PI3K
homozygotes that survived past birth died by P16, at embryos, they did display a subset of skeletal defects
observed in null mutants including cervical vertebraewhich time they were typically 40% the size of wt and
heterozygous littermates (4.7  1.2 g for PI3K versus malformations (14/14), abnormal development of the
shoulder girdle (14/14), spina bifida (13/14, 93%), and12.0  2.6 g for littermate controls; n  3). Respiratory
failure is likely to contribute to the observed postnatal failed closure of the sternum (4/14, 29%; Figures 3B and
3C and data not shown). Again, these skeletal defectslethality, since PI3K lungs were emphysematous in ap-
pearance and histological sections revealed failed alve- were never observed in Src homozygotes, suggesting
that a degree of specificity exists in usage of distinctolar septation, similar to that observed in PDGFA null
mice (Bostro¨m et al., 1996, and data not shown). PI3K PDGFR-activated signaling pathways for skeletal de-
velopment.homozygotes were retrieved at nearly the expected fre-
quency at E18.5 (29 PI3K/PI3K out of 138 embryos, 21%),
indicating that the majority of these mutants died perina- Multiple PDGFR-Initiated Signals Function
tally. PDGFR function has been previously shown as in Oligodendrocyte Development
essential for normal development of neural crest cell- Although Src homozygous mutants were recovered at
derived structures in the skull (Morrison-Graham et al., the expected frequency and were indistinguishable from
1992; Soriano, 1997). The palatal shelves that separate their littermates for the first 10–14 days following birth,
the nasopharynx and the oropharynx represent one such all of these animals subsequently began to exhibit neu-
structure. None of the PI3K homozygotes displayed the rological-related defects including shaking, spontane-
overt midline facial or nasal clefting characteristic of ous seizure, and decreased limb mobility. This pheno-
PDGFR null embryos. However, since one possible cause type appeared more severe on a mixed 129S4/C57BL6J
of death at birth is a cleft palate, skeletal preparations genetic background than on a congenic 129S4 genetic
of mutant and control embryos were performed. Consis- background. Furthermore, 60% of these animals die by
tent with the idea that signaling by the PDGFR through P35, although a few Src homozygotes have survived for
PI3K is required for optimal function of nonneuronal over 12 months. Multiple lines of evidence have estab-
cranial neural crest cells, the majority of PI3K homozy- lished PDGFAA/PDGFR signaling as essential for normal
development and function of oligodendrocyte progenitorgotes (10/14, 71%) displayed a cleft palate (Figure 3A).
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Figure 2. Biochemical Characterization of
the PDGFR Signaling Mutant Mouse Embry-
onic Fibroblasts
(A–F) Primary mouse embryonic fibroblasts
derived from homozygous signaling mutants
or littermate controls were rendered quies-
cent by overnight starvation in 0.1% calf se-
rum  ITS (5 g/ml insulin, 5 g/ml trans-
ferrin, and 5 ng/ml sodium selenite). Cells
were either left resting () or were stimulated
() for 5 min by addition of 30 ng/ml PDGFAA.
Cell lysates were subjected immediately to
SDS-PAGE or were immunoprecipitated with
the antibodies indicated above each panel,
and then they were analyzed by Western blot
or kinase assay. Total cell lysates probed for
PDGFR expression (A) or phosphorylated
MAP kinase (B). (C) PDGFR immunoprecipi-
tates analyzed for PDGFAA-dependent auto-
phosphorylation by phosphotyrosine West-
ern blot. MAP kinase activation is decreased
by 22% in the PI3K mutant fibroblasts com-
pared to wt and Src cell lines as determined
by NIH Image software. Immunoprecipitates
with the Src2 antibody that recognizes Src,
Yes, and Fyn were analyzed by standard in
vitro kinase assay in the presence of the sub-
strate enolase (D) and by phosphotyrosine (E)
and Src2 (F) Western blots.
(G–I) PDGFR immunoprecipitates were sub-
jected to SDS-PAGE and probed for the
PDGFR (G), the p85 subunit of PI3K (H), or
SHP-2 (I).
(J and K) Total cell lysates were analyzed for
PDGFAA-dependent phosphorylation by
Western blotting with anti-phospho-Akt (J)
and anti-Akt (K). Note that in the Akt blot, the
PDGFAA-stimulated band shift that corre-
sponds to phosphorylation observed in (K)
only occurs in wt and Src cells but not in PI3K
cells as expected. It is possible that the low
level of PDGF-induced Akt phosphorylation observed in the PI3K cells represents a small degree of indirect activation of PI3K. This may occur
via interaction with Ras or a tyrosine phosphorylated PDGFR-associated docking protein possessing binding sites for PI3K (Rodriguez-
Viciana et al., 1996).
cells (OPCs, also called O-2A progenitors), precursors knockout mice, the only region of the CNS where myelin-
ation appears relatively unaffected by loss of PDGFAA/of the myelin-forming cells of the central nervous system
(CNS). First, the PDGFR is expressed by OPCs (Pringle PDGFR signaling is the hindbrain (data not shown).
Our data complements the previous demonstration thatet al., 1992), while PDGFA is expressed by neurons and
astrocytes in the CNS (Richardson et al., 1988; Yeh et targeted deletion of the SFK Fyn in mice results in hypo-
myelination of the CNS due to abnormal developmental., 1991). Furthermore, PDGFAA has been shown to act
as a potent mitogen (Noble et al., 1988; Raff et al., 1988; of oligodendrocytes (Umemori et al., 1994). While these
studies indicate that activation of SFKs by the PDGFRRichardson et al., 1988), chemoattractant (Armstrong et
al., 1990), and survival factor (Barres et al., 1992) for is essential for CNS myelination, we cannot rule out the
possibility that other molecules capable of binding toOPCs in vitro. Finally, studies on transgenic mice that
overexpress PDGFA in neurons and on mice harboring Y572/Y574 also contribute to this process. To determine
whether the hypomyelination defect was specific to mu-a null allele of PDGFA have confirmed that PDGFAA is
the primary mitogen for OPCs in vivo (Calver et al., 1998; tation of the juxtamembrane autophosphorylation sites,
we analyzedPI3K mutants that survived to P16. Examina-Fruttiger et al., 1999). To determine whether the Src
mutants displayed hypomyelination of the CNS, various tion of sections from PI3K homozygotes revealed the
same hypomyelination defect (4/4; Figures 4B, 4E, andregions of the CNS were analyzed for the presence of
myelin by staining sections with Sudan Black (Figure 4). 4H). This indicates a requirement for activation of multi-
ple signals by the PDGFR to achieve normal myelina-While myelin staining was easily observed in multiple
regions rich in white matter on sections derived from tion of the CNS.
OPCs are generated from a specialized region of thewt mice (Figures 4A, 4D, and 4G), most regions of the
CNS from Src homozygotes displayed severe hypomy- ventral neuroepithelium and are recognized by their
characteristic expression of the PDGFR (Calver et al.,elination (6/6; Figures 4C, 4F, and 4I). Similar to PDGFA
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Figure 3. Skeletal Abnormalities Observed in PI3K but Not Src Homozygotes by Alizarin Red/Alcian Blue Staining of Embryonic Skeletons
(A) A ventral view of the skull derived from E17.5 embryos. The arrow points to the palatal shelves that divide the nasopharynx and the
oropharynx, which are closed in wt and Src embryos but remain opened in the majority of PI3K embryos through embryogenesis.
(B) Spina bifida is also caused by loss of PDGFR-mediated PI3K, but not SFK, signaling. Dissected 13th thoracic vertebrae (ribs removed)
derived from E18.5 wt and both signaling mutants are shown.
(C) Lack of PI3K signaling downstream of PDGFR activation also results in malformations of the shoulder girdle. Scapular blades and
associated acromions from E18.5 embryos are shown. Phenotypes varied from relatively normal (not shown), to weak, sometimes nonexistent
acromion formation, to more severe cases where duplication of the scapular blade is observed.
1998; Ellison and de Vellis, 1994; Fruttiger et al., 1999; progression of OPC development in our mutant and
control lines (Figure 5). Consistent with previous litera-Nishiyama et al., 1996; Pringle and Richardson, 1993;
Yu et al., 1994b). In the mouse embryonic spinal cord, ture, embryos that expressed a wt PDGFR allele over
the GFP allele displayed GFP-positive presumptiveOPCs are initially localized at E12.5 to the ventral ventric-
ular zone, then migrate dorsally and proliferate to evenly OPCs that localized to the ventral portion of the spinal
cord ventricular zone at E12.5 (Figure 5A). Populationpopulate the cord by E15.5 (Calver et al., 1998; Miller,
1996; Pringle and Richardson, 1993; Richardson et al., of the spinal cord by these GFP-positive OPCs also
progressed as expected, with cells migrating out of their1997). To determine whether the hypomyelination defect
was due to a failure of OPCs to populate the CNS, region of origin in a dorsal/lateral fashion at E13.5, then
proliferating and spreading evenly throughout the cordPDGFR signaling mutant heterozygotes were crossed
to mice in which a nuclear-localized version of the green by E15.5 (Figures 5A, 5D, and 5G). In contrast, expres-
sion of either signaling mutant over the GFP allele re-fluorescent protein (H2B-GFP) has been knocked into
the endogenous pdgfr genomic locus via homologous sulted in decreased ability of these cells to populate the
spinal cord. The defect appears to stem from an initialrecombination (T.G.H., R.A.K., and P.S., unpublished
data). This knockin, called GFP, disrupts expression of deficiency of OPCs to migrate away from their region
of origin (compare Figure 5B to 5E and Figure 5C to 5F).the pdgfr gene and replaces it with H2B-GFP, now
expressed under control of the endogenous PDGFR This is consistent with reports that both PI3K and SFKs
promote PDGFR-mediated chemotaxis in some cellpromoter. Since the PDGFR is recognized as a specific
marker for OPCs during embryogenesis (references types (Rosenkranz et al., 1999; Yu et al., 1994a). By
E15.5, some GFP-positive cells in PI3K and Src mutantscited above), we used expression of GFP to follow the
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Figure 4. Hypomyelination is observed in
most, but not all regions, of the CNS in both
PI3K and Src mutants
Vibratome sections (200 m) from different
regions of the CNS at P16 were stained for
myelin with Sudan Black.
(A-C) Cerebellum.
(D-F) Corpus callosum.
(G-I) Spinal cord taken from the level of the
cervical vertebrae.
are able to migrate away from the ventricular zone and undergoing apoptosis as detected by TUNEL staining or
in the mitotic index as judged by BrdU incorporationundergo proliferation (Figures 5H and 5I). However, very
few of these cells ever reach the dorsal-most regions (data not shown). In particular, we failed to detect in-
creased apoptosis or decreased proliferation in the dor-of the spinal cord, and the OPC population in both sig-
naling mutants remains dramatically reduced compared sal regions of the spinal cord, which have fewer OPCs.
Interestingly, previous in situ analysis shows that theto wt controls throughout embryogenesis (Figures 5G–
5L). Whether this represents a secondary deficiency in dorsal regions of the embryonic spinal cord express
lower levels of PDGFA than ventral regions, such asOPC mitogenesis or survival is unclear. However, exami-
nation of spinal cords at various developmental stages the motor neuron pools of the ventral horns, where the
strongest expression is observed (Calver et al., 1998).failed to reveal significant changes in the number of cells
Figure 5. Defective Oligodendrocyte Develop-
ment Is Observed in Both PI3K and Src Mutants
Heterozygous signaling mutant mice were
crossed to mice harboring the knockin of a
nuclear-localized GFP at the PDGFR locus
(GFP) to derive embryos expressing one allele
of the signaling mutant over the GFP allele.
Development and population of the spinal
cord by GFP-positive OPCs was followed
from E12.5 to E18.5 and progressed as ex-
pected in embryos expressing one wt allele
of the PDGFR (A, D, G, and J) (For compari-
son, see Calver et al., 1998). In contrast, OPC
migration away from their point of origin in
the ventricular zone is inhibited in PI3K (B and
E) and Src (C and F) mutants between E12.5
and E13.5. Although some mutant OPCs
eventually migrate out from the ventricular
zone, they fail to evenly populate the spinal
cord by the end of embryogenesis when my-
elination of the CNS begins (PI3K shown in [H
and K]; Src shown in [I and L]).
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Perhaps without the full repertoire of signaling pathways contrast, such signaling would be absent in the PDGFR
null mutants. If this route to activation of PI3K is relevantat its disposal, the PDGFR can only direct migration of
OPCs to the strongest sources of PDGFAA. Therefore, to embryogenesis, then elimination of the PI3K binding
sites on both PDGFRs should result in a phenocopy ofdisruption of PDGFR signaling through either PI3K or
SFKs is sufficient to prevent OPC development. This sug- the PDGFR null mutant. To test this possibility, we
crossed PI3K mice with mice harboring the analogousgests that in certain cells, distinct signaling pathways par-
ticipate in overlapping developmental contexts. mutation in the PDGFR (Heuchel et al., 1999; called
PI3K in this manuscript). Indeed, the phenotypic appear-
ance of PI3K/PI3K double homozygous mutants was veryPI3K Is the Major Effector of PDGFR Function
similar to that of PDGFR null embryos. These mutantsDuring Embryogenesis
displayed facial clefting, rib fusions, and blebbing alongAs described above, mutation of the PI3K binding sites
the trunk of the embryo (Figures 6E and 6F). Further-on the PDGFR results in defects in the same cell types
more, a proportion of these double mutants also dis-as those affected in PDGFR null embryos. However,
played earlier embryonic defects observed in PDGFRthe defects observed in PI3K mutants are less severe
knockout embryos, including growth retardation (Figurethan those seen in PDGFR null embryos. Furthermore,
6G). In the most severe cases, the double mutants failcertain defects observed in the null situation such as
to complete processes such as turning, fusion of thefacial clefting, subepidermal blebbing on the trunk of
chorion and allantois, and fusion of the neural folds bythe body, and fusion of the ribs have not been observed
midgestation (Figure 6H). Therefore, taken together withinPI3K mutants. Compensatory signaling by other signal-
the F7 results, this indicates that the reason the PI3King pathways left intact in the PI3K mutants may explain
mutant does not phenocopy the null is that it activatesthis difference in phenotype severity. To address this
PI3K via interaction with the PDGFR, not because ofpossibility, we created another line of knockin mice that
compensatory signaling through other PDGFR-acti-express a PDGFR; the line contained seven tyrosine
vated pathways. This also suggests that PI3K is theto phenylalanine mutations at the residues reported to
primary effector of PDGFR function during em-be required for binding of PI3K, SFKs, PLC, SHP-2, and
bryogenesis.one further residue that has not been fully characterized.
This mutant, called F7, has been previously analyzed in
fibroblasts and has been shown to be highly impaired Discussion
in assays for PDGFAA-driven mitogenesis, chemotaxis,
and activation of MAPK (Rosenkranz and Kazlauskas, An extensive effort over the last two decades has been
made to define the signal transduction mechanisms trig-1999). Surprisingly, F7 embryos, even as hemizygotes
(F7/), did not display abnormalities that were worse gered by RTK activation (Hunter, 2000; Schlessinger,
2000). As these mechanisms have become more de-than those observed in PI3K homozygous mutants. Other
than blebbing observed along the midline of the head fined, it has become clear that these receptors signal
by binding and activating characteristic arrays of intra-region, a phenotype also observed in PI3K/ embryos
(data not shown), F7/ mutants at E14.5 appeared more cellular signaling proteins. What remains unclear is how
each distinct signaling pathway activated contributessimilar to littermate controls than to PDGFR null em-
bryos (Figures 6A–6D). Furthermore, F7/ mutants sur- to the biological function of the receptor in an in vivo
context. Progress along this line has been made byvived until E18.5 and displayed skeletal abnormalities
very similar to those observed in PI3K mutants (data not several studies on mice expressing mutant RTKs that
are unable to activate a specific signaling pathway. Mostshown). Note that not all autophosphorylation sites are
eliminated in the F7 mutant. The binding site for the Crk of these analyses have shown that the mutants display
hypomorphic phenotypes that often affect a specificfamily of adaptor proteins is still intact; however, the
importance of these proteins to PDGFR function re- tissue or cell type (Blume-Jensen et al., 2000; Kissel et
al., 2000; Maina et al., 1996; Minichiello et al., 1998;mains unclear (Yokote et al., 1998). The observation
that PI3K and F7 phenotypes are essentially the same Partanen et al., 1998). However, it is difficult to interpret
whether the specific defects caused by these mutationssuggests that PI3K may act as a primary effector of
PDGFR function during embryogenesis. truly represent loss of signaling by a distinct effector
molecule or, alternatively, are the result of generalIf PI3K is the predominant effector of PDGFR func-
tion during embryogenesis, another explanation for the dampening of total receptor output. To truly determine
whether a specific signaling pathway is responsible fordifference between the PDGFR null and PI3K pheno-
types is that the PI3K receptor is still able to activate a mediating a unique biological function, multiple signal-
ing mutants must be analyzed downstream of a singlelow level of PI3K signaling by interacting with a surrogate
receptor that binds to PI3K. The PDGFR is the likely receptor. Here we have analyzed an allelic series of
PDGFR signaling mutants in mice. We find that muta-candidate as this surrogate receptor for PI3K activation,
since the two PDGFR isoforms form active heterodimers tions in either the PI3K or SFK binding sites on the
PDGFR impair oligodendrocyte development. In con-in response to several dimeric forms of PDGF (reviewed
in Betsholtz et al., 2001; Heldin et al., 1998). In cells trast, only mutation of the PI3K binding sites affects
skeletal development. Surprisingly, developmental ab-where both PDGFRs are expressed, the PI3K receptor
may transphosphorylate the PI3K binding sites on the normalities caused by PI3K site mutations were not ex-
acerbated in F7 embryos with mutations predicted toPDGFR. This signaling between the two subunits of
the heterodimer may activate enough PI3K to drive em- disrupt multiple signaling pathways. Consistent with a
predominant role for PI3K signaling in PDGF-mediatedbryogenesis to the perinatal stages of development. In
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Figure 6. PI3K Is the Primary Effector of
PDGFR Function In Vivo
(A and B) Front and lateral views of a PDGFR
null embryo at E13.5.
(C) An F7/ hemizygous embryo and wt lit-
termate at E14.5.
(D) Frontal view of the F7/ embryo shown in
(C). Note that while blebbing is observed
along the head, facial clefting is not observed
in this mutant.
(E) An PI3K/PI3K double homozygous embryo
at E13.5. Note the facial clefting and blebbing
along the body, similar to what is typically
observed in PDGFR null embryos at this
stage.
(F) Skeletal preparation of an PI3K/PI3K double
homozygote at E14.5 reveals rib fusions char-
acteristic of PDGFR null embryos.
(G and H) Earlier embryonic defects observed
at E10.5 displayed by PI3K/PI3K double homo-
zygotes include growth retardation and severe
developmental delay as described in the text.
functions during embryogenesis, embryos harboring a higher percentage of receptors than phosphorylation
of residues required for the binding of other proteinsmutations in the PI3K binding sites of both PDGFRs pheno-
copy the PDGFR null mutation. These results indicate that such as RasGAP (Kashishian et al., 1992). If the same
holds true for the PDGFR and the assumption is madewhile there is some overlap in the requirement for activa-
tion of different PDGFR signaling pathways in some cell that the potency of signaling by each effector protein
is similar, then, by virtue of having a greater numbertypes, distinct pathways make unequal contributions to
receptor function during mammalian development. of phosphotyrosine residues available for PI3K binding
than for other signaling molecules, PI3K would be pre-Multiple explanations exist as to why different devel-
opmental outcomes are observed when the PDGFR is dicted to be the primary effector of PDGFR signal trans-
duction. This could be further compounded by differ-uncoupled from distinct signaling pathways. It is possi-
ble that all signaling proteins essentially have the same ences in the affinity of the SH2 domains of the proteins
for binding to their respective phosphotyrosine residuespotential to execute RTK-mediated functions, but cell-
specific differences in expression of these proteins is the on the PDGFR. Indeed, the PDGFR contains two opti-
mized binding sites for the p85 subunit of PI3K, whereasprimary determinant of their importance to a particular
developmental event. Perhaps the ratio of SFK expres- optimal consensus binding sites for SFKs are not pres-
ent on this receptor (Songyang et al., 1993). Thus, sev-sion to PI3K expression is considerably higher in oligo-
dendrocytes than in neural crest cells. Therefore, while eral mechanisms exist to enhance usage of one specific
signaling protein over another in a purely quantitativewe are able to observe a requirement for both pathways
in oligodendrogenesis, normal skeletal patterning only manner, which could amplify the importance of a partic-
ular signaling protein in a specific developmental event.overtly requires signaling through PI3K. Alternatively,
differences in the stoichiometry of phosphorylation of While quantitative differences in engagement of sig-
naling pathways by RTKs may determine requirementsPDGFR residues could account for greater utilization
of one signaling protein over another. For instance, stud- for their activation in specific developmental processes,
it is also likely that qualitative differences in the signalingies on the PDGFR have shown that phosphorylation
of tyrosine residue 751, a PI3K binding site, occurs on capacities of effector proteins contribute to functional
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which introduced a ScaI site, was used (5	-GACGAGAGTACTAGAspecificity. Given the diversity in the biochemical func-
AGTTTTGTGATTTTG-3	). To introduce the phenylalanine substitu-tions of RTK-activated proteins, it is unlikely that these
tion at Tyr-731, the following oligonucleotide, which introduced aunique functions have evolved simply to promote the
SfuI site, was used (5	-TCTTTCGAAAATAACGGCGACTTCATGGA
same cellular responses upon growth-factor stimula- CATG-3	). To introduce the phenylalanine substitution at Tyr-742,
tion. Although proteins such as PI3K and SFKs have the following oligonucleotide, which introduced a BsrI site, was used
(5	-CAAGATGATACCACCCAGTTTGTCCCCATG-3	). To introducebeen implicated as effectors of similar sets of cellular
the phenylalanine substitution at Tyr-1018, the following oligonucle-functions including mitogenesis and chemotaxis, other
otide, which eliminates a Hae II site, was used (5	-CTGAGTGCTGAcellular responses may preferentially require the bio-
CAGTGGCTTCATCATCCCC-3	). In all cases, the restriction sitechemical activity of one signaling enzyme over another.
change did not alter the amino acid sequence of the PDGFR. All
A prominent example is the role of PI3K as an effector mutations that were initially selected based on restriction analysis
of growth factor-induced cell survival by virtue of its were confirmed by sequencing.
All constructs were linearized with SacII and electroporated intoability to activate the Akt kinase (Franke et al., 1997).
129S4-derived AK7 ES cells. Colonies were selected in G418 andSince the neural crest cell defect in PDGFR null em-
homologous recombination events were screened by PCR (Sorianobryos has been attributed to increased apoptosis (Sori-
et al., 1991), then verified by Southern blot using cDNA probes asano, 1997), failure of the PI3K mutant receptor to execute
described (Klinghoffer et al., 2001; Soriano, 1997). Correctly targeted
an anti-apoptotic signal could explain why development ES cells were used to generate germline chimeras by standard blas-
of neural crest-derived structures is more severely af- tocyst injection and transplant procedures. PCR genotyping was
performed on tail biopsies or yolk sac DNA as previously describedfected in mice expressing this mutant versus those ex-
for the pdgfr locus (Soriano, 1997). Both mixed background (C57/pressing Src.
Bl6J x129S4) and congenic 129S4 mice were analyzed in this study andThe idea that RTK-mediated activation of specific sig-
displayed indistinguishable phenotypes. In vivo deletion of PGKneonaling pathways is required to fulfill cell-specific func-
flanked by loxP sites was accomplished by crossing PDGFR knockin
tions in vertebrate development has been promoted re- mice to a germline Cre deleter strain, MORE (Tallquist and Soriano,
cently in a study by Maina et al. (2001). In this analysis, 2000). No difference in phenotype has been observed between neo
positive and neo negative PDGFR knockin mice.the multifunctional docking site of Met, which normally
Intriguingly, while chimeric mice derived from either heterozygousbinds to PI3K, SFKs, and Grb2, has been replaced with
wt PDGFR cDNA or Src ES cells produced extensive coat colormotifs that funnel Met signaling through just PI3K, or
chimerism (95%–100%), those derived from either heterozygousSFKs, or Grb2 (Met2P, Met2S, and Met2G, respectively) in
PI3K or F7 ES cells displayed very poor coat color chimerism (at
addition to signaling through Gab1. This study showed most 40% agouti) (data not shown). Despite the failure of these
that while Met2G mice developed normally, Met2P and mutant ES cells to contribute to coat color pigmentation, tail biop-
sies of PI3K and F7 chimeras revealed extensive contribution byMet2S mice displayed mutation-specific loss of function
mutant cells (over 75%), and breeding of these animals demon-phenotypes in different tissues and cell types (Maina et
strated germline transmission in the first litter. Heterozygous off-al., 2001). Together with our study, these results indicate
spring did not display a pigmentation defect. This result is similarthat at least in some cell types, different effector mole-
to what has been previously observed in chimeric animals derived
cules downstream of RTKs have the potential to execute from PDGFR null ES cells (Soriano, 1997) and suggests that muta-
qualitatively distinct developmental functions. tion of specific autophosphorylation sites results in a dosage-sensi-
tive cell-autonomous defect on coat color pigmentation.In summary, we have demonstrated that uncoupling
the PDGFR from distinct signaling pathways results in
Derivation of Cell Linesdistinguishable developmental outcomes. Our data also
Embryos were dissected at E14.5 in PBS, incubated for 5 min insuggest that PI3K acts as the predominant effector of
0.25% trypsin/1 mM EDTA at 37
C, teased apart first with sterilePDGFR signaling in vivo. This may reflect a quantitative
pipette tips and then by pipetting up and down with a transfer
difference in strength of signaling by PI3K versus other pipette, and plated onto gelatin-coated dishes. Cells were expanded
signaling proteins following activation by the PDGFR, until passage 2 before freezing. Primary mouse embryonic fibro-
or a qualitative difference in the ability of PI3K to transmit blasts were used for analysis between passages 3 and 5.
a specific biochemical signal that is required to drive
Western Blot Analysisessential cellular responses. This line of work builds on
Western blotting was performed as previously described (Kaz-pioneering studies performed over the past two decades
lauskas et al., 1992), with the exception that secondary antibodiesthat have biochemically defined RTK signal transduction
were conjugated to horseradish peroxidase instead of to alkaline
in cell culture, and begins to uncover how different phosphatase. The PDGFR (27P and 80.8), RasGAP (70.3), and MAP
growth factor-initiated signals are employed in the con- kinase antibodies (1913) used in this study were crude polyclonal
text of mammalian development. antisera raised against GST fusion proteins (Gelderloos et al., 1998;
Valius and Kazlauskas, 1993). The phospho-MAP kinase (91-10),
phospho-Akt (Ser473), and Akt antibodies were purchased from CellExperimental Procedures
Signaling Technology. The anti-phosphotyrosine antibody 4G10 was
purchased from Upstate Biotechnology. These antibodies wereDerivation of Knockin Mice
used according to manufacturer’s specifications.The targeting constructs used to derive the knockin strains were
essentially the same as those previously described for targeted
mutation of the pdgfr genomic locus (Klinghoffer et al., 2001), with In Vitro Src Kinase Assay
Cells were assayed for SFK tyrosine kinase activity as previouslythe exception that the PDGFR cDNA inserts encoded specific tyro-
sine to phenylalanine mutations introduced by site-directed muta- described (Klinghoffer et al., 1999). Briefly, cells were grown to near
confluence, starved overnight in DME  0.1% calf serum, and weregenesis. Site-directed mutagenesis was carried out by using the
Altered Sites II in vitro mutagenesis system kit by Promega. To left resting or were stimulated with PDGF. Cells were lysed and
immunoprecipitated with the anti-SFK polyclonal Src2 (Santa Cruz).introduce phenylalanine substitutions at Tyr-572/574, the following
oligonucleotide, which introduced a SalI site, was used (5	-GATG Immune complexes were collected and washed as previously de-
scribed (Kazlauskas et al., 1991). Src2 immunoprecipitates repre-GACATGAGTTTATCTTTGTCGACCCCATG-3	). To introduce the
phenylalanine substitution at Tyr-720, the following oligonucleotide, senting approximately 4  105 cells were subjected to a standard
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in vitro kinase assay in the presence of 1 Ci of [-32P]ATP and 0.5 binding to the carboxy terminus stimulates pp60c-src. Mol. Cell.
Biol. 6, 4467–4477.g of acid-denatured rabbit muscle enolase (Boehringer Mannheim)
as the exogenous substrate (Cooper and King, 1986). Samples were Ellison, J.A., and de Vellis, J. (1994). Platelet-derived growth factor
resolved by SDS-PAGE and visualized by autoradiography. All gels receptor is expressed by cells in the early oligodendrocyte lineage.
were stained with Coomassie blue to ensure that equal amounts of J. Neurosci. Res. 37, 116–128.
enolase were present in all samples.
Fambrough, D., McClure, K., Kazlauskas, A., and Lander, E.S. (1999).
Diverse signaling pathways activated by growth factor receptors
Skeletal Preparations induce broadly overlapping, rather than independent, sets of genes.
Embryos were fixed in 95% ethanol, stained at 37
C in 0.015% alcian Cell 97, 727–741.
blue/0.005% alizarin red/5% acetic acid in 70% ethanol, cleared in
Franke, T.F., Kaplan, D.R., Cantley, L.C., and Toker, A. (1997). Direct1% KOH, and transferred to solutions of decreasing KOH strength
regulation of the Akt proto-oncogene product by phosphatidylinosi-and increasing glycerol concentration.
tol-3,4-bisphosphate. Science 275, 665–668.
Fruttiger, M., Karlsson, L., Hall, A.C., Abramsson, A., Calver, A.R.,Myelin Staining
Bostrom, H., Willettes, K., Bertold, C.-H., Heath, J.K., Betsholz, C.,Central nervous system tissues were dissected out and placed im-
and Richardson, W.D. (1999). Defective oligodendrocyte develop-mediately into ice-cold 4% paraformaldehyde. Tissues were fixed
ment and severe hypomyelination in PDGF-A knock out mice. Devel-for 1 hr to O/N, rinsed thoroughly in PBS, and vibratome sectioned
opment 126, 457–467.(200 m). Sections were stained for 5–10 min in Sudan Black B
Gelderloos, J., Rosenkranz, S., Bazenet, C., and Kazlauskas, A.staining reagent (Sigma), rinsed in 70% ethanol at least three times,
(1998). A role for src in signal relay by the platelet-derived growthrefixed in 4% paraformaldehyde, and photographed.
factor alpha receptor. J. Biol. Chem. 273, 5908–5915.
GFP Analysis Heldin, C.-H., Ostman, A., and Ronnstrand, L. (1998). Signal trans-
PDGFR autophosphorylation site point mutant knockin mice were duction via platelet-derived growth factor receptors. Biochim Bio-
crossed to mice in which a histone 2B-GFP fusion protein has been phys. Acta 1378, F79–F113.
knocked into the PDGFR genomic locus. Studies from our lab have Hellstro¨m, M., Kalen, M., Lindahl, P., Abramsson, A., and Betsholtz,
shown that this GFP fusion protein, expressed under control of the C. (1999). Role of PDGF-B and PDGFR- in recruitment of vascular
endogenous PDGFR promoter, recapitulates the expected expres- smooth muscle cells and pericytes during embryonic blood vessel
sion pattern of the PDGFR in all embryonic and adult tissues formation in the mouse. Development 126, 3047–3055.
(T.G.H., R.A.K., and P.S., unpublished data). GFP-positive embryos
Heuchel, R., Berg, A., Tallquist, M., Ahlen, K., Reed, R.K., Rubin, K.,were fixed in 4% paraformaldehyde for 1 hr to O/N, vibratome sec-
Claesson-Welsh, L., Heldin, C.-H., and Soriano, P. (1999). Platelet-tioned (200 m), and photographed.
derived growth factor  receptor regulates interstial fluid homeosta-
sis through phosphatidylinositol-3	 kinase signaling. Proc. Natl.
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